1. Introduction {#sec1}
===============

Hypertrophy is defined as an increase in tissular volume of an organ, resulting from normal physiological process \[[@r1]\] or caused by abnormal accumulation of tissular components, such as hypertrophic scars or keloids occurred on human skin. In the latter case, the excessive growth of the scar can be of great cosmetic concern when occurring on the face, or result in functional loss of nearby organs \[[@r2]\]. Hypertrophic scars occurring in all age groups has higher incidence rate for individuals aged 10--20. They are common in African subjects following a traumatic event on skin. In some people, keloid may recur spontaneously after treatment.

Cutaneous hypertrophic scars are due to an accumulation of collagen cross-links (accounting for tissue hardening) and to an overproduction of collagen, raising above the surrounding skin or growing indefinitely beyond the boundaries of the original wound into a large, tumorous (although benign) neoplasm. Kischer and Brody \[[@r3]\] identified collagen nodules to be the structural unit of hypertrophic scars and keloids. These nodules, which are absent from mature scars, contain higher density of fibroblasts and unidirectional collagen fibrils in a highly organized and distinct orientation. In addition, hypertrophic scars differ from normal skin by the presence of richer vasculature (depending on scar age), higher mesenchymal cell density, and thickened epidermal cell layer. Keloidal scars, depending on their maturity, are mainly composed of either type III (early) or type I (late) collagen.

At present, clinical examination is the major method for hypertrophic scar tissue diagnosis. But, involving biopsy and subsequent histological analysis, it is of poor sensitivity and time-consuming \[[@r2]\]. Removal of the suspected scar tissue, leading to higher skin tension, would prolong the wound's healing and raise the risk of hypertrophy incidence. Thus, a non-invasive method for characterizing this kind of tissue *in vivo* is of prior interest for both clinicians and patients.

In the frame of developing non invasive diagnostic methods for *in vivo* tissue characterization, fibred optical spectroscopy has been widely studied over the last several decades \[[@r4]--[@r6]\]. In contrast to surgical biopsy, the spectroscopic methods don't require any tissue removal. The principle consists in exploiting tissue-light interactions between near-UV and near-infrared (NIR) to probe the optical properties of the biological tissues *in vivo*. The main interactions exploited are absorption, scattering and fluorescence \[[@r7]\]. The resulting intensity spectra are measured and serve for developing classification algorithms to automatically characterize the tissue states \[[@r8]--[@r10]\].

Light Induced Fluorescence Spectroscopy (LIFS) is one of the most studied spectroscopic methods for characterizing pathological tissues in cervix \[[@r11]--[@r13]\], esophagus \[[@r8]\], breast \[[@r14]\] and skin \[[@r19]\]. Biochemical and structural modifications associated to disease development can involve significant changes in intra-cellular and extra-cellular constituents among which some fluoresce under proper light excitation. These endogenous fluorophores include amino acids (tryptophan and tyrosine), structural proteins (collagen and elastin), pyridine nucleotides (NADH and NADPH), flavins and porphyrins. The AutoFluorescence (AF) emitted by these molecules is modulated by various factors, such as tissular concentration, quantum yield or biochemical environment. When pathological phenomena occur, these modulating factors are modified and change the bulk fluorescence intensity emitted by the tissue. Spatially resolved Diffuse Reflectance (DR) spectroscopy is another fibred optic technique efficiently applied in tissue photodiagnosis *in vivo* \[[@r11], [@r15], [@r16]\]. It consists in measuring the light backscattered by the tissue after multiple scattering and absorption of photons from an incident light over a wide wavelength band (350--750nm). The spectral features of the DR spectra depend on the scattering and absorbing properties of the tissue, involving main chromophores such as hemoglobin, melanin and water. A number of studies have demonstrated that the latter could change significantly for different tissue conditions \[[@r15], [@r17]\]. So, a diagnosis algorithm could be created by exploiting the optical-property-based spectroscopic features. The tissue depths to which the optical properties can be analyzed are determined by the multiple fiber probe geometry, as well as the excitation wavelength(s) \[[@r14]\]. Several fibers with different Collecting-to-Exciting Fiber separation (CEFS) are used for providing various probing depths, but with a limitation to the superficial layers of the tissue especially for UV-Visible wavelengths (a few hundreds of micrometers). Furthermore, numerous studies \[[@r8], [@r18]--[@r20]\] showed that each of these techniques separately provides complementary information on the tissue status, but that combining both (bimodal configuration) can bring superior diagnostic results.

As skin hypertrophy in scar tissues introduces a series of morphological and structural changes involving several fluorophores and chromophores (namely collagen, elastin, hemoglobin), we applied bimodal (multiple AF and DR) spectroscopy to diagnose hypertrophic scar tissues on a preclinical model. An anti-inflammatory drug, whose inhibition effect of hypertrophy formation had been tested along with this study, was partially applied to the model. We obtained not only hypertrophic but also non-hypertrophic scar tissues for spectra measurement. An experimental protocol was strictly followed for ensuring high quality data acquisition. Specific algorithms were developed for classifying each tissue site automatically based on discriminant spectroscopic features. The efficiency of the method was asserted upon sensibility and specificity obtained by comparing the classification results with those from histological analysis.

2. Materials and Methods {#sec2}
========================

2.1. Pre-clinical model {#sec2-1}
-----------------------

Up to the present, rabbit's ear is the only animal model that provides reproducible hypertrophic scar for *in vivo* study \[[@r36]\]. Hence, the protocol described in \[[@r36]\] was applied on 20 rabbits' ears to induce hypertrophic scar for our study. All procedures followed the Helsinki rules and were approved by the animal regional ethic committee of Northeastern France (january 2009). In brief (please refer to \[[@r23]\] for details), 20 New Zealand female white rabbits, between 2.5 and 4 kg and aged about 100 days (CEGAV, Les Hautes Noes, France), were kept under standard condition and fed *ad libitum* for 2 weeks before the experiment. Then, they were anesthetized by intramuscular injection of ketamine (45*mg*/*kg*) and xylazine (7*mg*/*kg*). The ventral surface of rabbits' ear was shaved and treated with chlorhexidine to avoid wound's infection. Two 10*mm*-diameter wounds were created on each ear with help of a circular dye cutter by removing the underneath perichondrium down to bare cartilage. The wounds were spaced from each other by 4 cm in order to avoid inter-wound reaction. They had been covered by Tegaderm dressing (Tegaderm, 3M Health Care, St.Paul, MN) until entirely re-epithelialized. Hypertrophic scars appeared basically in 28 days after the initial wounding. An immunomodulator drug with anti-inflammatory and antifibrinogenic proliferation properties (Tacrolimus), whose efficiency on inhibiting hypertrophic scar formation was investigated in \[[@r23]\], was applied to certain wounding in order to create non-hypertrophic scar tissues for comparison.

2.2. Spectroscopy instrumentation and measurement protocol {#sec2-2}
----------------------------------------------------------

The spatially resolved bimodal spectroscopic system used in the present work was adapted from the one developed by \[[@r19],[@r20]\]. In brief (see [Fig. 1](#g001){ref-type="fig"}), it consists of an infrared-filtered 300*W* Xenon arc lamp (PE30-BF PerkinElmer, Eurosep, France) producing excitation light in the range of 350--750*nm*. The lamp's output light is focused by a plano-convex lens on the entrance of a bunch of seven optical fibers (individual core diameter 200*μm*, numerical aperture 0.22) grouped together in a unique SMA connector. Between the light source and the SMA entrance, band-pass excitation filters (mounted on a filter wheel) and a couple of linearly variable short-and long-pass filters (LVF-series Linear Variable Filters, Ocean Optics) are used to configure the spectral shape of the excitation light for our experimental requirement. The positioning of all these filters is automated by linear or rotative motorized stages (LTA Long-Travel actuators and M-UMR8.51 linear stages, Newport) which are controlled by a dedicated motion controller (XPS motion controller, Newport). The use of this motion controller allow us programmable multi-excitation measurements. For DR measurements, a wide band excitation (350 -- 750*nm*) is required. In our experimental set-up, an extra linear motorized stage (Newport) was used during DR measurements to extend the travel distance of the LVFs so as to free the light path between the lens and the excitation fiber entrance.

![Schematics of the spatially resolved bimodal fibred spectroscopy set up. 1) Short arc Xenon Source 2) Heat control filter 3) Plano condenser lens 4) Wide band-pass filter wheel 5) Combined set of short- and long-pass linearly variable filters 6) Excitation fiber positioning stage 7) Micrometric translation stages 8) Fiber optics probe (distal tip) 9) Micrometric stage motor controller 10) Imaging Spectrograph 11) PC computer](boe-3-12-3278-g001){#g001}

In order to explore various tissue depths, 6 fibers were chosen to collect the light re-emitted by tissue at the 6 following CEFS : 429, 438, 453, 672, 696 and 1090*μm*. These collecting fibers are connected inline to the entrance slit of a multi-channel spectrometric system (iHR320 Imaging spectrometer, Symphony STE CCD, Jobin Yvon, HORIBA®). This system acquires the intensity spectra coming simultaneously from the 6 collecting fibers, allowing for spatially resolved measurements. The spectrometer features a diffraction grating groove of 150*gr*/*nm* density, which span the largest measure range (496*nm*) in keeping a relatively high spectral resolution (1.2*nm*). The spectrograph also features an internal filter wheel with 4 different long-pass filters alternatively used to eliminate the back-reflected excitation light from detection during AF measurements (see [Table 1](#t001){ref-type="table"}). For the present study, 9 narrow intensity peaks (FWHM= 15 ± 2*nm*) ranging from 360 to 450*nm* by step of 10*nm* were chosen for AF measurement, and a wide wavelength range 350 -- 700*nm* was used for DR measurement (cf. 1). The latter were automatically configured by loading a preset configuration file. A multi-excitation measurement on one tissue site, with 3 acquisitions in a row, takes about one minute and leads to a set of 180 spectra (9 AF and 1 DR spectra acquired 3 times at 6 CEFS).

###### 

Acquisition parameters of the multichannel spectrometer with Gain = 1.7, ADC frequency = 20kHz and Slit width = 0.5mm, Output power was measured at the distal tip of the fiber probe

  Measurements   Integration Time (*ms*)   Excitation Bands (*nm*)   Central peak Wavelength (*nm*)   Probe output Power (*μW*)   Emission Filters *λ~cut--off~* (*nm*)
  -------------- ------------------------- ------------------------- -------------------------------- --------------------------- ---------------------------------------
  AF             500                       352--368                  360                              220                         400
  362--378       370                       123                                                                                    
                                                                                                                                  
  372--388       380                       115                       435                                                          
                                                                                                                                  
  382--398       390                       109                       455                                                          
  392--408       400                       120                                                                                    
  402--418       410                       120                                                                                    
                                                                                                                                  
  412--428       420                       101                       475                                                          
  422--438       430                       103                                                                                    
  432--448       440                       103                                                                                    
                                                                                                                                  
  DR             200                       350--700                  \-                               1540                        no filter

From a metrological point of view, rigorous calibration procedures are needed to ensure all measured results are meaningful when compared to each others between individuals or among time \[[@r22]\]. [Table 2](#t002){ref-type="table"} summarizes the main calibration procedures performed on our programmable light source (including lamp, focusing lens, band-pass filters and excitation fibers of the probe) and on the detection channels (including sensing fibers of the probe, spectrograph's filter, diffraction grating and detector). The references of the corresponding calibration devices used for each metrological configuration are given together with the frequency of application of these procedures (before each measure, daily, monthly). These calibration results served to correct raw spectra through a series of preprocessing steps detailed in the next section.

###### 

Type of calibration measures performed for the experimental protocol with corresponding calibration devices and application frequencies

  Calibration Type                             Calibration device (references)                  Frequency
  -------------------------------------------- ------------------------------------------------ ---------------
  Wavelength calibration of the spectrograph   HgAr Lamp (LSP035 HgAr Line Source, LOT)         monthly
  Intensity response calibration               Calibrated Tungsten Lamp (DH-2000, Mikropack)    monthly
  Background substraction                      Shuttered light source                           every 2 hours
  Diffuse reflectance standard measurement     Integrating Sphere (ISP-30-6-IRRAD, Mikropack)   daily
  Illumination energy normalization            Power meter (841-PE + 818-UV, Newport)           daily

2.3. Histo-Clinical Analysis {#sec2-3}
----------------------------

After spectra measurement, each tissue site was removed for histological analysis under conventional optical microscopy. The thicknesses of tissues' epidermis, dermis, perichondrium and cartilage were measured for every scar tissue. The dermal lymphocytes and fibroblasts densities were also examined for evaluating the cellular proliferation of underline tissue. Based on these measurements, two quantitative parameters were calculated to characterize the tissue samples : Dermal Fibroblasts Density (DFD) and Scar Elevation Index (SEI) \[[@r23]\]. SEI is a parameter related to the volume increase of tissue after scarring defined as the ratio between the scar elevation thickness (*h~ss~* -- *h~ns~*) over the original thickness (*h~ns~*) of the skin. DFD was measured by counting the number of fibroblasts per *μm*^2^ in a tissue section. According to these criteria, all tissue samples were tagged as hypertrophic or non-hypertrophic by two experts. In short (please refer to \[[@r23]\] for details), mean dermal thickness, SEI and DFD are significantly higher in Hypertrophic scars (HT) than in Non-Hypertrophic scars (NHT) with p¡0.05 (Student's t-Test, n=25). The resulting classification (30 hypertrophic and 25 non-hypertrophic) was used as gold standard for developing our spectroscopic data-based classification algorithm. Examples of tissue slices and of rabbit'ear scars are given in [Fig. 2](#g002){ref-type="fig"}.

![(a), (b), (c) Images of histological slices for normal and scar tissues (Hematoxylin and Eosin stains). (d) scars on the ventral side of an anesthetized rabbit's ear. (e) fiber probe positioning piece. (f) irregular scar tissue (28 days after surgical wound)](boe-3-12-3278-g002){#g002}

3. Preprocessing of the raw spectra {#sec3}
===================================

Firstly, all acquired spectra were subtracted by a background spectrum measured at the same day with shuttered light source. Then, 3 subsequent spectra obtained under each configuration (every couple of excitation and CEFS) were averaged to obtain a higher SNR (Signal-to-Noise Ratio). A median filter with window frame size of 3 points (2.34*nm*) eliminated high amplitude narrow artifacts, while a Savitzky-Golay filter with window size of 25 points (20.25*nm*) eliminated high frequency noises by smoothing the spectra. Each intensity value of a AF spectrum was multiplied by a corresponding correction factor obtained by the spectral response calibration procedure (tungsten lamp). The spectrally corrected AF spectra were then normalized to the illumination power and exposure time for eliminating the influence of excitation intensity variations \[[@r22]\]. At last, all preprocessed spectra were normalized to their individual maximum for a line-shape analysis mentioned hereafter.

4. Spectroscopic Data Analysis {#sec4}
==============================

4.1. Initial selection of proper measurement sites {#sec4-1}
--------------------------------------------------

The strong light absorption due to erythema on some tissue sites deformed some acquired spectra to such an extent that they were not exploitable. Therefore, a revision algorithm eliminating all the data measured on these tissue sites was necessary before performing the spectral data classification. In general, these over-distorted spectra exhibiting quite different line-shape have intensity values non-correlated to those measured on most of tissue sites in the same class. Therefore, the median value of the inter-correlation vector of each spectrum was compared to a threshold (in our case 70%) so that a spectrum was considered as outlier if the value was less than the threshold i.e. eliminated from the data pool. By this method, we retained 44 (22 hypertrophic and 22 non-hypertrophic) out of 55 tissue sites for further analysis. The analysis of the tissue surface photographs and of the histological slice images confirmed the initial assumption that a very high blood level due to inflammatory reaction was found for most of these 11 eliminated sites.

4.2. Feature extraction {#sec4-2}
-----------------------

In order to extract discriminant features for classification, we first calculated the mean spectrum of each spectra class. The line-shapes of the class mean spectra represent the general spectral features in each class (intra-class spectra). The comparison of their line-shapes can help us to reveal discriminant features between spectra of different classes (inter-class spectra). A discriminant feature should be, for the most part, found in the spectral ranges where the intra-class spectra has more uniform intensity values and the inter-class ones differ the most. Here, intensity standard deviation (SD) was used to examine the intensity uniformity of the intra-class spectra. [Fig. 3](#g003){ref-type="fig"} shows the mean spectra and SD calculated for the normalized AF intensity spectra excited at 360*nm* and measured at the 5th CEFS (430*μm*). For both HT and NHT classes, the intensity spectra show a higher uniformity in the range between 400 and 680*nm* (SD ∈ \[0.016, 0.0519\]). Hence, a threshold value of 0.05 was fixed for locating these "uniformity" ranges in all spectra acquired under different system configurations.

![Mean±SD peak-normalized spectra excited at 368nm and measured at the CEFS of 438*μm* for (a) normal (*n* = 22), (b) hypertrophic scar (HT, *n* = 22) and (c) non-hypertrophic scar (NHT, *n* = 22) tissues. (d) Mean AF spectra for hypertrophic (bold line) and non-hypertrophic (dotted line) tissues excited at 368*nm* and measured at the 5th CEFS. The spectra are divided into 4 wavelength bands of 73nm width each (A :385--456nm, B :457--530nm, C :531--605nm, D :606--679nm) with respective correlation values : 0.943, 0.999, 0.999 and 0.866.](boe-3-12-3278-g003){#g003}

For locating the wavelength ranges where inter-class spectra (AF and RD) differ the most, another algorithm was developed based on the comparison of mean spectra correlations. Indeed, when two data sets are different, they must be independent and have relatively low correlation. Thus, we divided the class mean spectral curve into several pieces of equal size and analyzed locally their differences by calculating piece to piece their intensity correlation. As can be seen in [Fig. 3](#g003){ref-type="fig"}, the ranges where the class mean spectra differ more from each other have low correlation values (in the frames of A and D). On the other hand, the piece lengths defined for the correlation comparison can vary for revealing spectral differences at various scales. So, the mean spectra were segmented using various sizes (4 to 73 nm) and the piece to piece correlations were calculated at these different scales. A correlation threshold value of 0.95 was used to consider a wavelength range as "discriminant", and therefore of interest for carrying out the final feature extraction.

Interesting spectral features to be exploited can be either intensity absolute values or any other parameters representing the spectral line-shape like : mean intensities, under-curve areas, intensity or area ratios, slopes \[[@r18]--[@r20]\]. In a number of studies, statistical methods like Principle Component Analysis (ACP) have also been applied to the entire spectra in order to decompose the spectra into a linear combination of orthogonal basis (uncorrelated) spectra called Principal Components (PCs) \[[@r8], [@r24]\]. The first PC accounts for the spectral features that represents the most variation of the original data, and the subsequent ones represent features with progressively smaller variance. To describe a specific spectrum, a linear combination of PCs is used, with each PC weighted by the appropriate PC score. Typically, the value of these PC scores are used in classification but their complexity (linear combinations of numerous raw spectral intensities) is finally not easy to deal with, especially when it comes to the discussion on the signification of a limited exploitable number of intensity points.

The feature extraction implemented here addressed spectral features characterizing the line-shape of the normalized spectra of different tissues groups. Thus, the spectral slope was thought to be more interesting to exploit than other features and used alone as classification features. For calculating the slopes in each wavelength range, a linear least-square method was used to determine a line that has the best fit to the spectral curve spanning range. Finally, 486 slope characteristics in total were extracted from spectra (9AF + DF) measured for each scar site.

4.3. Feature selection {#sec4-3}
----------------------

As presented in \[[@r25]\], though many candidate features are introduced to better represent the class domain due to unknown underlying class probabilities, the irrelevant and redundant features potentially present in the data set may affect the learning algorithm and reduce the classification performance. In addition, the large size of the 486-variables data set makes the classification problem more complicated, time-consuming, and yield a poor generalizing capability. A non-parametric significance statistical test (Mann-Whitney-Wilcoxon) was first applied to each feature, so as to examine whether its distribution was significantly independent for the two underlined classes. After this step, we obtain a subset of 112 features whose distribution was significantly independent for the different classes. Then, a heuristic method of stepwise regression was implemented for further feature selection. We started with a forward iterative selection procedure, during which variables were added one by one into the underline subset. The added feature remained in the subset if it enhanced the classification accuracy in terms of increasing the under-curve area in a Receiver Operating Characteristic (ROC). Otherwise, the feature was discarded. The iteration ended up when all features had been tested once. Afterward, the features in the resulting subset were discarded one by one, in order to examine if their abandoning would reduce the classification accuracy. If so, the discarded feature was included again in the subset, and otherwise definitely eliminated from the pool. At the end of these consecutive selection procedures, only 4 features were retained for the final classification (see [Table 3](#t003){ref-type="table"}).

###### 

Set of the 4 selected slope features used for classification

  CEFS (*μm*)   Excitation wavelength (*nm*)   AF emission wavelength bands (*nm*)   feature F
  ------------- ------------------------------ ------------------------------------- -----------
  429           368                            484 -- 531                            F1
  438           410                            528 -- 599                            F2
  453           420                            532.5 -- 591.5                        F3
  672           410                            626 -- 648                            F4

4.4. Supervised classification {#sec4-4}
------------------------------

The efficiency of a regularized linear classifier (Fisher's Linear Discriminant Analysis, LDA) and a non-regularized non-linear classifier (k-Nearest Neighbors, k-NN) were comparatively tested in the present study. Considering a linear combination of the characteristics, the first method aims at splitting the high-dimensional input space with a separation hyperplane. This separator is found by maximizing the ratio of between-class variance to the within-class variance. LDA can handle classification problems where the within-class frequencies are unequal and is well-regularized even when the data dimension is large such as in \[[@r19]\]. As for the k-NN, it provides non linear decision boundaries. It projects data of a test sample onto a multidimensional feature space consisting of the data from a labeled training set. The test sample is assigned with the most found class in its neighborhood including the k nearest training samples. This technique is simple and can deal with problems where data are totally confused. In addition, it can offer a good classification accuracy for low dimension problems which may be the case in our study, because the number of features was efficiently reduced in previous steps \[[@r18]\].

Leave-One-Out (LOO) cross-validation method \[[@r16], [@r19], [@r26]\] was performed to obtain unbiased classification results. In practice, one tissue site is excluded from the data set and k-NN (with k = 1) or LDA classifier is applied to the rest of this data set to generate a classifying scheme. The resulting scheme is then used to classify the previously excluded site. The classification result is compared to that obtained by the gold standard, such as histological analysis. We note 1 if the tissue site was correctly classified, and 0 otherwise. This process was repeated until all sites were excluded and tested once. The classification efficiency was asserted upon Sensibility (Se) and Specificity (Sp) calculated by the ratio of well classified to total tissue sites.Finally, we obtained the following results for each classifier : *Se* = 85.7% and *Sp* = 94.4% for LDA, *Se* = 90.5% and *Sp* = 94.4% for k-NN. The k-NN method gave the highest positive predictive and negative predictive values of 94.2% and 90.8% respectively.

5. Discussion {#sec5}
=============

Looking at the final 4 most discriminant spectral features F1--F4 in [Table 3](#t003){ref-type="table"}, it can be noticed that none of them is relative to DR spectra. This observation implies the light absorption and diffusion due to chromophores (such as melanin and hemoglobin) do not contribute to the changes in DR spectra in a significantly enough way for differentiating between HT and NHT tissues. On the contrary, the absorption and scattering effects may partially contribute to discriminant changes in AF spectra. The curve-shape distortions of the *in vivo* AF spectra can be associated to changes in namely structural organization of the Extra-Cellular Matrix (ECM), blood volume, oxygen saturation of hemoglobin and mean depth of blood vessels and related to hypertrophic and non-hypertrophic cicatricial skin tissues. The 4 selected slopes are those of AF intensity spectra collected at excitation wavelengths 360, 410 and 420 nm, which puts forward their specific discrimination efficiency and also the relationship between hypertrophic tissues and the constitutive fluorophores excited at these wavelengths.

[Table 4](#t004){ref-type="table"} summarizes AF emission wavelength peaks and bands of the main skin fluorophores reported by previous studies using excitations around 370, 410 and 420*nm*. The epidermis is an avascular stratified squamous epithelium in which keratinocytes form the major proliferating cellular constituent. The dermis is a highly vascularized conjunctive layer in which assemble the collagen and elastin fibers into dense arrays \[[@r19], [@r20]\]. In hypertrophic skin, the tissue overgrowth is related to increased metabolic activity. Flavins and NADH, two major intra-cellular co-enzyme involved in metabolism mechanisms with emission peak respectively at 535*nm* and 460*nm*, are interesting for targeting this mechanism change \[[@r4], [@r27], [@r28]\]. Porphyrins are intermediate products in the cellular cycle characterized by two emission peaks at 635 and 670 nm \[[@r4]\]. Using spectral imaging to investigate the morphological structure changes in hypertrophic tissues, Chen et al. \[[@r21]\] found that collagen fiber network was disorganized and disrupted, resulting in a lower level of second harmonic generation signal on the fluorescent image. The distribution of elastin fibers was also disrupted but accumulated in a higher quantity in hypertrophic tissues thus generating more intense fluorescence. Collagen and elastin are structural proteins constituting the extracellular matrix in dermis. Their cross-links have a relatively high quantum efficiency compared with their monomers \[[@r37]\]. Cross-linking of fibrils is the origin of collagen fluorescence which emission peak (460 to 500*nm*) shifts with excitation (370 to 420*nm*). Same observation has been reported for elastin with emission peak shifts from 470 to 500*nm*.

###### 

AF emission wavelength peaks and bands reported in the literature for main skin endogenous fluorophores in epidermis and dermis (corresponding embedded layers in last row) excited at wavelengths 370, 410 and 420 nm.

  Excitation wavelength (*nm*)   AF emission wavelength peaks and bands (*nm*)                                           
  ------------------------------ ----------------------------------------------- ---------- ---------- -------- -------- -----------
  370                            450--470                                        530--550              460      470      475
  410                            450--470                                        530--550   635, 670   490      480      
  420                            450--470                                        530--550   635, 670   490      480      500
                                                                                                                         
  Embedded place                 cells                                           cells      cells      dermis   dermis   epidermis

When looking at the excitation-emission wavelength combinations relative to our discriminant features shown in [Table 3](#t003){ref-type="table"}, we could make some potential links between the information carried by : -- F1 and the biochemical changes in the epidermis (relative to keratin), in the dermis (elastin), and in both layers (flavins),-- F2 and F3 together, and changes relative to keratin in the epidermis, collagen in the dermis, and mainly flavins and lipopigments in both layers,-- F4 and the modifications associated to porphyrins in the epidermal and dermal cells.

It is worth noting that the 3 shortest feature-relative CEFS are close from each others (429, 438 and 453 *nm*). Indeed, for spatially resolved spectroscopy, using multiple collecting fibres at different CEFS can explore various tissue depths. For instance, it has been reported that using a CEFS of 250 *μm* allow excitations in the wavelength range 337 -- 400*nm* arrive at depths of 225 -- 250*μm* in skin tissues \[[@r33], [@r34]\]. \[[@r35]\] mentioned the maximum probing depth in an homogeneous medium (localized at *CEFS*/2) can be defined as $z_{\mathit{\max}} = \mathit{CEFS}/2\sqrt{2}$. The [Fig. 4](#g004){ref-type="fig"} synthesizes the mean thickness (±SD)of epidermis and dermis measured for healthy, hypertrophic and non-hypertrophic samples, and the corresponding maximal exploring depths of our collecting probes defined by the aforementioned equation at feature-relative excitation wavelengths (below 420*nm*). It can be noticed that the 4 most discriminant features are obtained for the 4 firsts CEFS (429, 438, 453, 672 *μm*) among those tested here, offering a probing depth between 203 and 308*μm* (see [Fig. 4](#g004){ref-type="fig"}). In this probing depth, dermis accounts for the major part in healthy tissue. However, during the scarring process, both epidermis and dermis thickness increases for hypertrophic and non-hypertrophic tissue. With this structural change, the exploring tissue portion changes and exhibits in the form of measured spectral line-shape, because fluorophores embedded in dermis give less and less contribution to the measured AF spectra.

![Schematic representation of the correspondences between mean thicknesses measured for healthy, hypertrophic (HT) and non-hypertrophic (NHT) tissue samples and the maximum penetration depth of excitation lights below 420*nm* in relation with the two main discriminant CEFS 440 and 670*μm*](boe-3-12-3278-g004){#g004}

The difference in fluorescence intensity between HT and NHT can also be reflected on the extracted features, though it is not as evident as on the images. This may be due to compensation of intensity contribution of two fluorophores excited (collagen and elastin) and emitting fluorescence in the same wavelength range \[[@r21]\]. Therefore, it could be interesting to test other spectral features, such as intensities ratio, for which the difference might be more pronounced. This could further enhance the classification performance. The obtained results corroborate the fact that morphological modifications in the matrix fiber network observed through a point spectroscopy modality may be a good tool to help the clinician for identifying scared skin tissue boundaries or for tracking skin scar formation.

6. Conclusion {#sec6}
=============

In this study, the efficiency of bimodal (multi-AF and DR) spectroscopy was investigated in the detection of hypertrophic scar tissue on a preclinical model. A specific feature extraction and selection algorithm was developed and validated on our spectral data for classifying hypertrophic and non-hypertrophic tissues, giving a sensibility of 90.5% and a specificity of 94.4%. Interpretation has been given relative to the discriminant features found by our extraction/selection methods. To our knowledge, this is the first use of spectroscopic methods on hypertrophic scar tissue. Considering this relative high diagnostic accuracy, our methods and findings can complete the future usage of spectroscopy in clinical dermatology.
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